Moreover, high expression levels of CP are correlated with malignant potential in esophageal cancer, bile duct cancer, renal cell carcinoma, and adrenocortical carcinoma [45,46,47,48]. This evidence concerns the gene CP and hereditary clear cell renal cell carcinoma.